Catalyst Wire Dossier Catalyst Wire Dossier

mRNA lipid nanoparticle encoding native-like HIV-1 envelope trimer boost

mRNA-LNP HIV envelope trimer booster · National Institute of Allergy and Infectious Diseases (NIAID)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA lipid nanoparticle encoding native-like HIV-1 envelope trimer boost, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV [Phase 1]

See pricing